Thyronamines - Past, present, and future

Endocrine Reviews

Volumn 32, Issue 1, 2011, Pages 64-80

  Piehl, S ^a   Hoefig, C S ^a   Scanlan, T S ^b   Köhrle, Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; DIIODOTHYRONINE; IODOTHYRONAMINE; LIOTHYRONINE; THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; THYROMIMETIC AGENT; THYRONAMINE; TOSYLARGININE METHYL ESTER; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER;

ADULT; ARTICLE; BIOSYNTHESIS; CASE REPORT; CHRONOTROPISM; DEAMINATION; DEIODINATION; DRUG ACTIVITY; DRUG BINDING SITE; DRUG METABOLISM; DRUG STRUCTURE; DRUG SULFATION; DRUG TRANSPORT; GLUCOSE METABOLISM; GOITER; HUMAN; HYPERGLYCEMIA; HYPOTHERMIA; INOTROPISM; KETONURIA; METABOLIC RATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY QUOTIENT; SIGNAL TRANSDUCTION; STROKE;

ADIPOSITY; ANIMALS; CRICETINAE; HEART RATE; HUMANS; HYPERGLYCEMIA; HYPOTHERMIA; KETOSIS; MALE; MICE; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; STROKE; THYRONINES;

EID: 79951605794     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2009-0040     Document Type: Article

References (79)

1. Scanlan TS 2009 Minireview: 3-iodothyronamine (T1AM): a new player on the thyroid endocrine team? Endocrinology 150:1108-1111
2. Zucchi R, Chiellini G, Scanlan TS, Grandy DK 2006 Trace amine-associated receptors and their ligands. Br J Pharmacol 149:967-978 (Pubitemid 44950800)
3. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10:638-642 (Pubitemid 38796856)
4. Cody V, Meyer T, Dohler KD, Hesch RD, Rokos H, Marko M 1984 Molecular structure and biochemical activity of 3,5,3′-triiodothyronamine. Endocr Res 10:91-99 (Pubitemid 14037220)
5. DeBarber AE, Geraci T, Colasurdo VP, Hackenmueller SA, Scanlan TS 2008 Validation of a liquid chromatographytandem mass spectrometry method to enable quantification of 3-iodothyronamine from serum. J Chromatogr A 1210: 55-59
6. Braulke LJ, Klingenspor M, DeBarber A, Tobias SC, Grandy DK, Scanlan TS, Heldmaier G 2008 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J Comp Physiol B 178:167-177 (Pubitemid 351164900)
7. Hillmann G, Keil B, Taslimi P 1958 [Determination of thyroxamine in the thyroid gland and plasma.]. Z Naturforsch B 13B:820-821
8. Meyer T, Hesch RD 1983 Triiodothyronamine-a β-adrenergic metabolite of triiodothyronine? Horm Metab Res 15:602-606
9. Hillmann G, Keil B 1961 [The distribution of I-131-labelled thyroxamine in the body of the rat.]. Z Gesamte Exp Med 134:380-382
10. Pinna G, Brödel O, Visser T, Jeitner A, Grau H, Eravci M, Meinhold H, Baumgartner A 2002 Concentrations of seven iodothyronine metabolites in brain regions and the liver of the adult rat. Endocrinology 143:1789-1800 (Pubitemid 34415894)
11. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, DeBarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK, Scanlan TS, Zucchi R 2007 Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J 21:1597-1608 (Pubitemid 46684861)
12. Geraci T, Fjeld C, Colasurdo V, Samuels M, Schuff K, Scanlan T 3-Iodothyronamine (T1AM) levels in human serum and tissue. Proc 79th Annual Meeting of the American Thyroid Association, Chicago, IL, 2008 (Abstract)
13. Soldin O, Gu J, Soldin SJ Thyronamines: tandem mass spectrometry quantification in biological fluids. Proc 80th Annual Meeting of the American Thyroid Association, Palm Beach, FL, 2009, pp S-114 (Abstract 37)
14. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B, Köhrle J 2008 Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149:3037-3045 (Pubitemid 351724541)
15. Benvenga S, Gregg RE, Robbins J 1988 Binding of thyroid hormones to human plasma lipoproteins. J Clin Endocrinol Metab 67:6-16
16. Harington C, Thibault O 1953 [Comparison of the sensitizing activity of triiodothyronine and thyroxin as well as their corresponding amines.]. C R Seances Soc Biol Fil 147: 78-81
17. Thibault O 1957 [Action of tri- and tetraiodothyropyruvic acids on oxygen consumption in euthyroid rat.]. CR Seances Soc Biol Fil 151:475-479
18. Tomita K, Lardy HA 1956 Synthesis and biological activity of some triiodinated analogues of thyroxine. J Biol Chem 219:595-604
19. Dratman MB 1974 On the mechanism of action of thyroxin, an amino acid analog of tyrosine. J Theor Biol 46:255-270
20. Doyle KP, Suchland KL, Ciesielski TM, Lessov NS, Grandy DK, Scanlan TS, Stenzel-Poore MP 2007 Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke 38:2569-2576 (Pubitemid 47329639)
21. Dhillo WS, Bewick GA, White NE, Gardiner JV, Thompson EL, Bataveljic A, Murphy KG, Roy D, Patel NA, Scutt JN, Armstrong A, Ghatei MA, Bloom SR 2009 The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. Diabetes Obes Metab 11:251-260
22. Ghelardoni S, Suffredini S, Frascarelli S, Brogioni S, Chiellini G, Ronca-Testoni S, Grandy DK, Scanlan TS, Cerbai E, Zucchi R 2009 Modulation of cardiac ionic homeostasis by 3-iodothyronamine. J Cell Mol Med 13:3082-3090
23. Zucchi R, Ghelardoni S, Chiellini G 2010 Cardiac effects of thyronamines. Heart Fail Rev 15:171-176
24. Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, Tonacchera M, Vitti P, Scanlan TS, Zucchi R 2010 Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151:5063-5073
25. Boissier JR, Giudicelli JF, Larno S, Advenier C 1973 Differential inotropic-chronotropic action of thyronamine. Eur J Pharmacol 22:141-149
26. Côté P, Polumbo RA, Harrison DC 1974 Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action. Cardiovasc Res 8:721-730
27. Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, Scanlan TS, Hebrok M, Coughlin SR 2007 Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 117:4034-4043 (Pubitemid 350224112)
28. Klieverik LP, Foppen E, Ackermans MT, Serlie MJ, Sauerwein HP, Scanlan TS, Grandy DK, Fliers E, Kalsbeek A 2009 Central effects of thyronamines on glucose metabolism in rats. J Endocrinol 201:377-386
29. Swoap SJ, Gutilla MJ, Liles LC, Smith RO, Weinshenker D 2006 The full expression of fasting-induced torpor requires β3-adrenergic receptor signaling. J Neurosci 26:241-245 (Pubitemid 43089537)
30. Hudson JW, Scott IM 1979 Daily torpor in the laboratory mouse, Mus musculus var. albino. Physiol Zool 52:205-218
31. Snead AN, Santos MS, Seal RP, Miyakawa M, Edwards RH, Scanlan TS 2007 Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS ChemBiol 2:390-398 (Pubitemid 350001561)
32. Felt V, Ploc I 1982 Effect of theophylline on binding of triiodothyronine, thyroxine, thyroxamine, tetraiodothyroacetic acid and cortisol in the cytosol of human leukocytes. Endokrinologie 79:315-317 (Pubitemid 12008653)
33. Felt V, Ploc I 1981 Effect of theophylline on binding of L-triiodothyronine (T3) to cytosolic receptors of human leukocytes. Endokrinologie 77:109-111 (Pubitemid 11123566)
34. Buu-Hoi NP, Pham-Huu-Chanh, Petit L 1966 Some biological effects of thyronamine. Med Pharmacol Exp Int J Exp Med 15:17-23
35. Tan ES, Naylor JC, Groban ES, Bunzow JR, Jacobson MP, Grandy DK, Scanlan TS 2009 The molecular basis of species-specific ligand activation of trace amine-associated receptor 1 (TAAR(1)). ACS Chem Biol 4:209-220
36. Hart ME, Suchland KL, Miyakawa M, Bunzow JR, Grandy DK, Scanlan TS 2006 Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. J Med Chem 49:1101-1112 (Pubitemid 43221656)
37. Panas HN, Lynch LJ, Vallender EJ, Xie Z, Chen GL, Lynn SK, Scanlan TS, Miller GM 2010 Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. J Neurosci Res 88:1962-1969
38. Bylund DB, Ray-Prenger C, Murphy TJ 1988 α-2A and α-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245:600-607
39. Liggett SB 2004 The two-timing thyroid. Nat Med 10:582-583 (Pubitemid 38796845)
40. Hoefig CS, Schlärmann P, Piehl S, Bertoldi M, Scanlan TS, Schweizer U, Kohrle J Towards the identification of iodothyronine decarboxylases. Proc 34th Annual meeting of the European Thyroid Association, Lisbon, Portugal, 2009, pp 138 (Abstract)
41. Köhrle J 2002 Iodothyronine deiodinases. Methods Enzymol 347:125-167 (Pubitemid 34233269)
42. Piehl S, Heberer T, Balizs G, Scanlan TS, Köhrle J 2008 Development of a validated liquid chromatography/tandem mass spectrometry method for the distinction of thyronine and thyronamine constitutional isomers and for the identification of new deiodinase substrates. Rapid Commun Mass Spectrom 22:3286-3296
43. Pietsch CA, Scanlan TS, Anderson RJ 2007 Thyronamines are substrates for human liver sulfotransferases. Endocrinology 148:1921-1927 (Pubitemid 46457140)
44. Wood WJ, Geraci T, Nilsen A, DeBarber AE, Scanlan TS 2009 Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo. Chembiochem 10:361-365
45. Wu SY, Green WL, Huang WS, Hays MT, Chopra IJ 2005 Alternate pathways of thyroid hormone metabolism. Thyroid 15:943-958 (Pubitemid 41339272)
46. Ianculescu AG, Giacomini KM, Scanlan TS 2009 Identification and characterization of 3-iodothyronamine intracellular transport. Endocrinology 150:1991-1999
47. Cheng SY, Leonard JL, Davis PJ 2010 Molecular aspects of thyroid hormone actions. Endocr Rev 31:139-170
48. Moreno M, de Lange P, Lombardi A, Silvestri E, Lanni A, Goglia F 2008 Metabolic effects of thyroid hormone derivatives. Thyroid 18:239-253 (Pubitemid 351271526)
49. Scapin S, Leoni S, Spagnuolo S, Gnocchi D, De Vito P, Luly P, Pedersen JZ, Incerpi S 2010 Short-term effects of thyroid hormones during development: focus on signal transduction. Steroids 75:576-584
50. Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK2009 Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab 297:E1238-E1246
51. Wrutniak-Cabello C, Casas F, Cabello G 2001 Thyroid hormone action in mitochondria. J Mol Endocrinol 26:67-77 (Pubitemid 32125122)
52. Lombardi A, de Lange P, Silvestri E, Busiello RA, Lanni A, Goglia F, Moreno M 2009 3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement. Am J Physiol Endocrinol Metab 296: E497-E502
53. Mollica MP, Lionetti L, Moreno M, Lombardi A, De Lange P, Antonelli A, Lanni A, Cavaliere G, Barletta A, Goglia F 2009 3,5-Diiodo-L-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. J Hepatol 51:363-370
54. Ribeiro MO, Bianco SD, Kaneshige M, Schultz JJ, Cheng SY, Bianco AC, Brent GA 2010 Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-β isoform specific and required for adaptive thermogenesis. Endocrinology 151:432-440
55. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J 2006 Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:484-489 (Pubitemid 43152840)
56. Lei J, Bhargava M, Ingbar DH 2009 Cell-specific signal transduction pathways regulating Na+-K+-ATPase. Focus on "short-term effects of thyroid hormones on the Na+-K+-ATPase activity of chick embryo hepatocytes during development: focus on signal transduction." Am J Physiol Cell Physiol 296:C1-C3
57. Moeller LC, Cao X, Dumitrescu AM, Seo H, Refetoff S 2006 Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor β through the phosphatidylinositol 3-kinase pathway. Nucl Recept Signal 4:e020
58. Luidens MK, Mousa SA, Davis FB, Lin HY, Davis PJ 2010 Thyroid hormone and angiogenesis. Vascul Pharmacol 52: 142-145
59. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ, Stachelek SJ, Leonard JL 2005 Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3′,5′-triiodothyronine. Brain Res Dev Brain Res 154:121-135 (Pubitemid 40023136)
60. Scarlett A, Parsons MP, Hanson PL, Sidhu KK, Milligan TP, Burrin JM 2008 Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin αVβ3. J Endocrinol 196:509-517 (Pubitemid 351425506)
61. Tomanek RJ, Zimmerman MB, Suvarna PR, Morkin E, Pennock GD, Goldman S 1998 A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart. J Mol Cell Cardiol 30:923-932 (Pubitemid 28279305)
62. Zheng W, Weiss RM, Wang X, Zhou R, Arlen AM, Lei L, Lazartigues E, Tomanek RJ 2004 DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling. Am J Physiol Heart Circ Physiol 286:H1994-H2000 (Pubitemid 38525491)
63. Guran T, Turan S, Bircan R, Bereket A 2009 9 Years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC). J Pediatr Endocrinol Metab 22:971-978
64. Torre P, Bertoli M, Di Giovanni S, Scommegna S, Conte C, Novelli G, Cianfarani S 2005 Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy. J Endocrinol Invest 28:657-662 (Pubitemid 43162877)
65. Radetti G, Persani L, Molinaro G, Mannavola D, Cortelazzi D, Chatterjee VK, Beck-Peccoz P 1997 Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 7:775-778 (Pubitemid 28086211)
66. Sherman SI, Ringel MD, Smith MJ, Kopelen HA, Zoghbi WA, Ladenson PW 1997 Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine. J Clin Endocrinol Metab 82:2153-2158 (Pubitemid 27287576)
67. Hill Jr SR, Barker SB, McNeil JH, Tingley JO, Hibbett LL 1960 The metabolic effects of the acetic and propionic acid analogs of thyroxine and triiodothyronine. J Clin Invest 39: 523-533
68. Stamler J 1977 The coronary drug project-findings with regard to estrogen, dextrothyroxine, clofibrate and niacin. Adv Exp Med Biol 82:52-75
69. Baxter JD, Webb P 2009 Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 8:308-320
70. Grover GJ, Mellström K, Ye L, Malm J, Li YL, Bladh LG, Sleph PG, Smith MA, George R, Vennström B, Mookhtiar K, Horvath R, Speelman J, Egan D, Baxter JD 2003 Selective thyroid hormone receptor-β activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proc Natl Acad Sci USA 100: 10067-10072 (Pubitemid 37098262)
71. Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, Angelin B, Baxter JD 2008 The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc Natl Acad Sci USA 105:663-667
72. Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B 2010 Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med 362:906-916
73. Hoefig CS, Köhrle J, Brabant G, Dixit K, Strasburger CJ, Wu Z A novel chemiluminescent immunoassay identifies 3-iodothyronamine in human serum and provides evidence for its extrathyroidal formation. 14th International Thyroid Congress, Paris, France, 2010, Oral communications, Late Breaking Communication LB10 (Abstract)
74. Bhargava M, Lei J, Mariash CN, Ingbar DH 2007 Thyroid hormone rapidly stimulates alveolar Na, K-ATPase by activation of phosphatidylinositol 3-kinase. Curr Opin Endocrinol Diabetes Obes 14:416-420
75. Köhrle J 2000 The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability. Rev Endocr Metab Disord 1:49-58
76. Brenta G, Schnitman M, Fretes O, Facco E, Gurfinkel M, Damilano S, Pacenza N, Blanco A, Gonzalez E, Pisarev MA 2003 Comparative efficacy and side effects of the treatment of euthyroid goiter with levo-thyroxine or triiodothyroacetic acid. J Clin Endocrinol Metab 88:5287-5292 (Pubitemid 37452729)
77. Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RC, Scanlan TS 1998 A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol 5:299-306 (Pubitemid 28309983)
78. Mousa SA, O'Connor LJ, Bergh JJ, Davis FB, Scanlan TS, Davis PJ2005The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol 46:356-360
79. Morkin E, Pennock GD, Spooner PH, Bahl JJ, Goldman S 2002 Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 12:527-533 (Pubitemid 34721552)